Elizabeth Bilsland

The current COVID-19 pandemic highlighted the vulnerability of our society to infections diseases. Whilst the current media focus is centered on SARS-CoV2, we must be prepared for the threat posed by drug-resistant parasites, fungi, and bacteria. The Synthetic Biology Laboratory (LaBS) was established in 2016 and is based on synthetic biology as a tool for drug discovery, using yeast and bacteria as hosts for heterologous expression and a platform for genome-wide screens. We have 3 well-established lines of investigation, which can further be improved and rapidly yield results.

Jose Luiz Proenca Modena

Since 2015, José is professor in the Department of Genetics, Evolution, Microbiology and Imunology, Institute of Biology at University of Campinas (Unicamp). Currently, he heads a Laboratory of Emerging Viruses (LEVE) where he is conducting researches about pathogenesis of Oropouche virus (OROV), Zika virus (ZIKV), Chikungunya virus (CHIKV) and the recently discovered new Coronavirus (SARS-CoV-2).

Ana Paula Couto Davel

Our primary research focus is to understand functional and molecular mechanism underlying vascular complications on cardiovascular and metabolic diseases such as obesity, undernutrition and dyslipidemias. The laboratory uses in vivo and in vitro experimental approaches including blood pressure measurement, the study of vascular function and structure, and biochemical and molecular biology methods.